Mesco Pharma Fact Sheet, Mesco Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Mesco Pharma Fact Sheet    (MESC)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of Mesco Pharma. For more details, see the Mesco Pharma quarterly results and Mesco Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

MESCO PHARMA Price History

Price Rs 5.7
Mkt Cap Rs m 116
Vol '000 0.2
P/E X -2,312.5
P/CF X -117.6
EPS (TTM) Rs -0.0
% ch % 0.0
No. of shares m 20.32
% ch week % 0.0
% ch 1-mth % 0.0
% ch 12-mth % -
52 week H/L Rs 7.7/3.6
(As on Sep 6, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

MESCO PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
MESCO PHARMA EQUITY SHARE DATA
High RsNANANA1212 
Low RsNANANA99 
Sales per share (Unadj.) Rs00000 
Earnings per share (Unadj.) Rs0-0.10-0.20 
Diluted earnings per shareRs0.0-0.10.0-0.20.0 
Cash flow per share (Unadj.) Rs0-0.10-0.20 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %NMNMNM00 
Book value per share (Unadj.) Rs-5.0-5.1-5.2-5.4-5.4 
Adj. book value per shareRs-5.0-5.1-5.2-5.4-5.4 
Shares outstanding (eoy) m20.3220.3220.3220.3220.32 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio xNMNMNMNMNM 
Avg P/E ratio x000-53.1-216.2 
P/CF ratio (eoy) x000-53.1-216.2 
Price / Book Value ratio x000-2.0-1.9 
Dividend payout %00000 
Avg Mkt Cap Rs m000218212 
No. of employees `000NANANANANA 
Total wages/salary Rs m00000 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
MESCO PHARMA INCOME DATA
Net Sales Rs m00000 
Other income Rs m00000 
Total revenues Rs m00000 
Gross profit Rs m0-3-1-4-1 
Depreciation Rs m00000 
Interest Rs m00000 
Profit before tax Rs m0-3-1-4-1 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00000 
Profit after tax Rs m0-3-1-4-1 
Gross profit margin %NMNMNMNMNM 
Effective tax rate %34.1-0.4000 
Net profit margin %NMNMNMNMNM 
MESCO PHARMA BALANCE SHEET DATA
Current assets Rs m00000 
Current liabilities Rs m00000 
Net working cap to sales %NMNMNMNMNM 
Current ratio x3.04.95.71.72.6 
Inventory Days DaysNMNMNMNMNM 
Debtors Days DaysNMNMNMNMNM 
Net fixed assets Rs m22222 
Share capital Rs m197197197197197 
"Free" reserves Rs m-299-302-302-307-308 
Net worth Rs m-102-104-105-109-110 
Long term debt Rs m104107107111112 
Total assets Rs m22222 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x-1.0-1.0-1.0-1.0-1.0 
Sales to assets ratio x00000 
Return on assets %8.4-104.4-35.2-165.2-44.9 
Return on equity %-0.22.50.83.80.9 
Return on capital %13.4-107.5-36.2-182.9-48.0 
Exports to sales %NMNMNMNMNM 
Imports to sales %NMNMNMNMNM 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
MESCO PHARMA CASH FLOW
From Operations Rs m 0 -3 -1 -4 -1 
From Investments Rs m 0 0 0 0 0 
From Financial Activity Rs m 0 3 1 4 1 
Net Cashflow Rs m 0 0 0 0 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 39.3%
Institution 0.0%
Non-Institution 60.7%
Total 100.0%
Free Float 60.7%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Upper Kesalton, Tallital, Nainital - 263001
E-MAIL nsparameswaran@mescosteel.com WEB www.mescopharma.com
TEL 09871862796 FAX
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Skyline Financial Services Pvt Ltd, D-153/A 1st Floor, Okhla Industrial Area, Phase - I
YEAR OF INC: 1986 BSE CODE: 500274 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   HULTA PHARMA  FERVENT SYNERGIES  ASTRAZENECA PHARMA  KOPRAN.  FDC  

Compare MESCO PHARMA With:   HULTA PHARMA  FERVENT SYNERGIES  ASTRAZENECA PHARMA  KOPRAN.  FDC  




Today's Market

5 Reasons Why Sensex Plunged 525 Points Today(Closing)

It was indeed a volatile day for Indian share markets today. Tracking a rout in the global markets, benchmark indices tumbled for the second day.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MESCO PHARMA

  • Track your investment in MESCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MESCO PHARMA

MESCO PHARMA - TEVA PHARMA COMPARISON

COMPARE MESCO PHARMA WITH

MARKET STATS